Real-time enrollment status for this viral lung infection clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 5:49 PM UTC
| NCT Number | NCT05624450 |
| Recruiting Status | Recruiting |
| Condition | Viral Lung Infection |
| Phase | PHASE3 |
| Target Enrollment | 3,527 participants |
| Active Locations | 76 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 28, 2026 (3 days ago) |
As of August 31, 2026: Clinical trial NCT05624450 is currently recruiting participants. This phase3 study for viral lung infection is actively seeking new participants at 76 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05624450 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 76 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05624450 was last updated 3 days ago (August 28, 2026). HelloStudys verifies this status automatically.